You searched for oral corticosteroids

CHEST 2022

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

October 19, 2022

Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.

News

Non-Vitamin K Antagonist Oral Anticoagulants vs Warfarin in NVAF Patients

August 20, 2021

Findings may help with decision-making in this high-risk patient population.

ATS 2021, News

Oral Corticosteroid Dose Management With Impaired Adrenal Function Evaluated

May 14, 2021

Patients with normal adrenal function are largely able to eliminate the use of oral corticosteroids or achieve a daily dose of 5 mg or less.

AAAAI 2021, News

Benralizumab May Reduce or Eliminate Oral Corticosteroid Use in Severe Asthma

March 1, 2021

Patients with asthma who depend on oral corticosteroids (OCS) may be able to reduce the dependence or eliminate the use of OCS altogether with benralizumab.

News

Drug-Induced Immunosuppression Examined in US Adults

June 3, 2021

Drug-induced immunosuppression, particularly from oral corticosteroids, may limit response to COVID-19 vaccine

ACAAI 2022

Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

November 21, 2022

The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.

ACAAI 2022

Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

November 16, 2022

Investigators assessed the annualized asthma exacerbation rate (AAER) and the annualized rate of asthma exacerbations requiring hospitalization over 52 weeks.

CHEST 2022

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

October 18, 2022

Investigators explored the value of treating patients with bronchiolitis in primary Sjogren’s Syndrome using inhaled corticosteroids and long-acting beta agonists.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

Active Filters

Your search for oral corticosteroids returned 29 results

Sort Results:

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

Non-Vitamin K Antagonist Oral Anticoagulants vs Warfarin in NVAF Patients

Oral Corticosteroid Dose Management With Impaired Adrenal Function Evaluated

Benralizumab May Reduce or Eliminate Oral Corticosteroid Use in Severe Asthma

Drug-Induced Immunosuppression Examined in US Adults

Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers